306 related articles for article (PubMed ID: 15214912)
41. Primary ALK-positive anaplastic large cell lymphoma of the breast: a case report and review of the literature.
Daneshbod Y; Oryan A; Khojasteh HN; Rasekhi A; Ahmadi N; Mohammadianpanah M
J Pediatr Hematol Oncol; 2010 Mar; 32(2):e75-8. PubMed ID: 20168249
[TBL] [Abstract][Full Text] [Related]
42. Anaplastic Large Cell Lymphoma.
Medeiros LJ; Elenitoba-Johnson KS
Am J Clin Pathol; 2007 May; 127(5):707-22. PubMed ID: 17511113
[TBL] [Abstract][Full Text] [Related]
43. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type.
Pileri SA; Pulford K; Mori S; Mason DY; Sabattini E; Roncador G; Piccioli M; Ceccarelli C; Piccaluga PP; Santini D; Leone O; Stein H; Falini B
Am J Pathol; 1997 Apr; 150(4):1207-11. PubMed ID: 9094977
[TBL] [Abstract][Full Text] [Related]
44. Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood.
Hutchison RE; Banki K; Shuster JJ; Barrett D; Dieck C; Berard CW; Murphy SB; Link MP; Pick TE; Laver J; Schwenn M; Mathew P; Morris SW
Ann Oncol; 1997; 8 Suppl 1():37-42. PubMed ID: 9187427
[TBL] [Abstract][Full Text] [Related]
45. CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma.
Ait-Tahar K; Barnardo MC; Pulford K
Cancer Res; 2007 Mar; 67(5):1898-901. PubMed ID: 17332315
[TBL] [Abstract][Full Text] [Related]
46. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
47. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
[TBL] [Abstract][Full Text] [Related]
48. ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as "leukemic phase".
Lu Y; Zhao X; Wang E; Chen W; Huang Q
Leuk Res; 2010 Apr; 34(4):475-82. PubMed ID: 19695703
[TBL] [Abstract][Full Text] [Related]
49. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus association and ALK gene expression in anaplastic large-cell lymphoma.
Agarwal S; Ramanathan U; Naresh KN
Hum Pathol; 2002 Feb; 33(2):146-52. PubMed ID: 11957137
[TBL] [Abstract][Full Text] [Related]
51. The anaplastic lymphoma kinase in the pathogenesis of cancer.
Chiarle R; Voena C; Ambrogio C; Piva R; Inghirami G
Nat Rev Cancer; 2008 Jan; 8(1):11-23. PubMed ID: 18097461
[TBL] [Abstract][Full Text] [Related]
52. A novel complex t(2;5;13)(p23;q35;q14) in small cell variant type anaplastic large cell lymphoma with peripheral involvement.
Kong SY; Cho HJ; Suk JH; Tak EY; Ko YH; Kim K; Kim SH
Cancer Genet Cytogenet; 2004 Oct; 154(2):183-5. PubMed ID: 15474159
[TBL] [Abstract][Full Text] [Related]
53. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.
Pulitzer M; Ogunrinade O; Lin O; Steinherz P
J Cutan Pathol; 2015 Mar; 42(3):182-187. PubMed ID: 25404214
[TBL] [Abstract][Full Text] [Related]
54. ALK-positive neutrophil-rich variant of anaplastic large cell lymphoma diagnosed after head trauma.
Tamiolakis D; Papadopoulos N; Venizelos J; Kakagia D; Nikolaidou S; Bolioti S; Kouskoukis C
Onkologie; 2005 Jun; 28(6-7):356-8. PubMed ID: 15933425
[TBL] [Abstract][Full Text] [Related]
55. Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation.
Damm-Welk C; Klapper W; Oschlies I; Gesk S; Röttgers S; Bradtke J; Siebert R; Reiter A; Woessmann W
Br J Haematol; 2009 Aug; 146(3):306-9. PubMed ID: 19545284
[TBL] [Abstract][Full Text] [Related]
56. Serpin A1 is overexpressed in ALK+ anaplastic large cell lymphoma and its expression correlates with extranodal dissemination.
Duplantier MM; Lamant L; Sabourdy F; de Reynies A; Delsol G; Espinos E
Leukemia; 2006 Oct; 20(10):1848-54. PubMed ID: 16900211
[TBL] [Abstract][Full Text] [Related]
57. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
Wood GS; Hardman DL; Boni R; Dummer R; Kim YH; Smoller BR; Takeshita M; Kikuchi M; Burg G
Blood; 1996 Sep; 88(5):1765-70. PubMed ID: 8781433
[TBL] [Abstract][Full Text] [Related]
58. The role of p53 and anaplastic lymphoma kinase genes in the progression of cutaneous CD30(+) lymphoproliferative diseases.
Kapur S; Tiemann M; Menke MA; Schubert C; Parwaresch R
Indian J Med Res; 2005 Jan; 121(1):46-54. PubMed ID: 15713979
[TBL] [Abstract][Full Text] [Related]
59. Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature.
Grewal JS; Smith LB; Winegarden JD; Krauss JC; Tworek JA; Schnitzer B
Ann Hematol; 2007 Jul; 86(7):499-508. PubMed ID: 17396261
[TBL] [Abstract][Full Text] [Related]
60. Anaplastic large cell lymphoma: a flow cytometric analysis of 29 cases.
Kesler MV; Paranjape GS; Asplund SL; McKenna RW; Jamal S; Kroft SH
Am J Clin Pathol; 2007 Aug; 128(2):314-22. PubMed ID: 17638668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]